• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小肠移植中供体淋巴组织的替代

Replacement of donor lymphoid tissue in small-bowel transplants.

作者信息

Iwaki Y, Starzl T E, Yagihashi A, Taniwaki S, Abu-Elmagd K, Tzakis A, Fung J, Todo S

机构信息

Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania.

出版信息

Lancet. 1991 Apr 6;337(8745):818-9. doi: 10.1016/0140-6736(91)92517-6.

DOI:10.1016/0140-6736(91)92517-6
PMID:1707470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2983478/
Abstract

The presence of recipient lymphocytes in grafts is thought to equate with rejection. Thus, we wished to follow the fate of lymphocytes after transplant of the small bowel. Three complete small-bowel transplants, two with the liver from the same donor also transplanted, were done successfully. Patients were immunosuppressed with FK 506. 5 to 11% of lymphocytes in the recipients' peripheral blood were of donor origin during the early postoperative period when there were no clinical signs of graft-versus-host disease. However, donor cells were no longer detectable after 12 to 54 days. Serial biopsy specimens of the grafted small bowel showed progressive replacement of lymphocytes in the lamina propria by those of the recipient's HLA phenotype. Lymphoid repopulation was complete after 10 to 12 weeks but the epithelial cells of the intestine remained those of the donor. The patients are on enteral alimentation after 5, 6, and 8 months with histopathologically normal or nearly normal intestines. Re-examination of assumptions about the rejection of intestinal grafts and strategies for its prevention are required following these observations.

摘要

移植物中存在受者淋巴细胞被认为等同于排斥反应。因此,我们希望追踪小肠移植后淋巴细胞的命运。成功进行了3例全小肠移植,其中2例还同时移植了来自同一供者的肝脏。患者接受FK 506免疫抑制治疗。术后早期,当没有移植物抗宿主病的临床症状时,受者外周血中5%至11%的淋巴细胞来自供者。然而,12至54天后就不再能检测到供者细胞。移植小肠的系列活检标本显示,固有层中的淋巴细胞逐渐被具有受者HLA表型的淋巴细胞所取代。10至12周后淋巴细胞再填充完成,但肠上皮细胞仍为供者的细胞。5、6和8个月后,患者接受肠内营养,肠道组织病理学检查正常或接近正常。基于这些观察结果,需要重新审视关于肠道移植物排斥反应的假设及其预防策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/953b/2983478/2befaedb9166/nihms245747f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/953b/2983478/2befaedb9166/nihms245747f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/953b/2983478/2befaedb9166/nihms245747f1.jpg

相似文献

1
Replacement of donor lymphoid tissue in small-bowel transplants.小肠移植中供体淋巴组织的替代
Lancet. 1991 Apr 6;337(8745):818-9. doi: 10.1016/0140-6736(91)92517-6.
2
Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).美国的肠道和多脏器移植:20年国家登记数据报告(1990 - 2009年)
Clin Transpl. 2009:83-101.
3
Small bowel transplant: an evidence-based analysis.小肠移植:基于证据的分析。
Ont Health Technol Assess Ser. 2003;3(1):1-72. Epub 2003 Apr 1.
4
Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.大鼠小肠移植中供体或受体术前使用FTY720后的排斥反应。
Transpl Immunol. 2004 Nov;13(3):161-8. doi: 10.1016/j.trim.2004.06.004.
5
Evidence that indefinite survival of small bowel allografts achieved by a brief course of cyclosporine or FK506 is not due to systemic hyporesponsiveness.环孢素或FK506短期疗程实现的小肠同种异体移植长期存活并非由于全身低反应性的证据。
Transplantation. 1992 Sep;54(3):505-10. doi: 10.1097/00007890-199209000-00022.
6
Intestinal graft versus native liver cytokine expression in a rat model of intestinal transplantation with and without donor-specific cell augmentation.在有和没有供体特异性细胞增强的大鼠小肠移植模型中,小肠移植物与天然肝脏的细胞因子表达。
J Surg Res. 2003 Sep;114(1):78-89. doi: 10.1016/s0022-4804(03)00211-7.
7
Immunologic benefits of longer graft in rat allogenic small bowel transplantation.大鼠同种异体小肠移植中较长移植物的免疫学益处。
Transplantation. 2005 Jan 27;79(2):190-5. doi: 10.1097/01.tp.0000149323.79759.5b.
8
Twenty-five consecutive isolated intestinal transplants in adult patients: a five-yr clinical experience.25例成年患者连续进行的孤立性肠道移植:五年临床经验
Clin Transplant. 2007 Mar-Apr;21(2):177-85. doi: 10.1111/j.1399-0012.2007.00620.x.
9
Experimental study of combined treatment with tacrolimus and donor splenocytes via the portal vein in small bowel transplantation.他克莫司与供体脾细胞经门静脉联合治疗在小肠移植中的实验研究
J Med Invest. 2001 Aug;48(3-4):157-65.
10
The use of FK506 and RS61443 for reversal of small-bowel rejection.
Transpl Int. 1992;5 Suppl 1:S274-7. doi: 10.1007/978-3-642-77423-2_87.

引用本文的文献

1
Immune cell profiling in intestinal transplantation.肠移植中的免疫细胞分析。
Hum Immunol. 2024 Jul;85(4):110808. doi: 10.1016/j.humimm.2024.110808. Epub 2024 May 18.
2
Bortezomib for treatment-refractory autoimmune haemolytic anaemia following multivisceral transplantation.硼替佐米用于多脏器移植后难治性自身免疫性溶血性贫血的治疗。
BMJ Case Rep. 2021 May 12;14(5):e241634. doi: 10.1136/bcr-2021-241634.
3
Characterization of donor and recipient CD8+ tissue-resident memory T cells in transplant nephrectomies.移植肾切除术中供体和受体 CD8+ 组织驻留记忆 T 细胞的特征。
Sci Rep. 2019 Apr 12;9(1):5984. doi: 10.1038/s41598-019-42401-9.
4
Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome.双向移植物内同种异体反应性驱动人肠道同种异体移植物的再填充,并与临床结果相关。
Sci Immunol. 2016 Oct;1(4). doi: 10.1126/sciimmunol.aah3732. Epub 2016 Oct 7.
5
Long-term Persistence of Innate Lymphoid Cells in the Gut After Intestinal Transplantation.肠道移植后肠道内固有淋巴细胞的长期持续存在。
Transplantation. 2017 Oct;101(10):2449-2454. doi: 10.1097/TP.0000000000001593.
6
Implications of Resident Memory T Cells for Transplantation.驻留记忆T细胞对移植的影响。
Am J Transplant. 2017 May;17(5):1167-1175. doi: 10.1111/ajt.14101. Epub 2016 Dec 9.
7
Intestine and multivisceral transplantation: current status and future directions.肠道及多脏器移植:现状与未来方向
Curr Gastroenterol Rep. 2015 Jan;17(1):427. doi: 10.1007/s11894-014-0427-8.
8
The concept of gut rehabilitation and the future of visceral transplantation.肠道康复的概念与内脏移植的未来
Nat Rev Gastroenterol Hepatol. 2015 Feb;12(2):108-20. doi: 10.1038/nrgastro.2014.216. Epub 2015 Jan 20.
9
Mixed chimerism and split tolerance: mechanisms and clinical correlations.混合嵌合与分裂耐受:机制及临床关联
Chimerism. 2011 Oct-Dec;2(4):89-101. doi: 10.4161/chim.2.4.19017.
10
The Role of Cell Migration and Chimerism in Organ Transplant Acceptance and Tolerance Induction.细胞迁移与嵌合体在器官移植接受及耐受诱导中的作用
Transplant Sci. 1993 Apr 1;3(1):47-50.

本文引用的文献

1
Origin of lymph node-derived lymphocytes in human hepatic allografts.人肝移植中淋巴结来源淋巴细胞的起源
Clin Transpl. 1989;3:316-324.
2
Homotransplantation of multiple visceral organs.多个内脏器官的同种移植
Am J Surg. 1962 Feb;103:219-29. doi: 10.1016/0002-9610(62)90491-9.
3
Transplantation of small bowel in the rat: technical and immunological considerations.大鼠小肠移植:技术与免疫学考量
Surgery. 1971 Nov;70(5):693-702.
4
Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients.心肺移植受者支气管肺泡淋巴细胞与巨噬细胞之间的相互作用
Hum Immunol. 1985 Nov;14(3):287-94. doi: 10.1016/0198-8859(85)90236-8.
5
Expression of major histocompatibility complex antigens and replacement of donor cells by recipient ones in human liver grafts.人类肝脏移植物中主要组织相容性复合体抗原的表达及受者细胞对供者细胞的替代
Transplantation. 1987 Feb;43(2):291-6. doi: 10.1097/00007890-198702000-00025.
6
Lymphocyte infiltration patterns in rat small-bowel transplants.大鼠小肠移植中的淋巴细胞浸润模式。
Transplant Proc. 1990 Dec;22(6):2460.
7
Successful small-bowel/liver transplantation.成功的小肠/肝脏移植。
Lancet. 1990 Jan 27;335(8683):181-4. doi: 10.1016/0140-6736(90)90275-a.
8
Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506.使用FK506预防大鼠同种异体骨髓移植后的移植物抗宿主病。
Transplantation. 1991 Oct;52(4):590-4. doi: 10.1097/00007890-199110000-00002.
9
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506.在FK 506作用下,大鼠多脏器同种异体移植与孤立小肠同种异体移植后的长期存活情况
Surgery. 1991 Jul;110(1):87-98.
10
Use of FK 506 in pediatric patients.FK506在儿科患者中的应用。
Transplant Proc. 1991 Feb;23(1 Pt 2):924-7.